Report cover image

Global Sinusitis Treatment Market Size, Share, and Analysis, By Disease (Acute Sinusitis, Sub-acute Sinusitis, and Chronic Sinusitis), By Age (Paediatrics, Adults), By Treatment (Surgery, Analgesics, Corticosteroids, Antihistamines, Quinolones, Antibiotic

Publisher Fatpos Global
Published Dec 01, 2023
Length 371 Pages
SKU # FAGL18583699

Description

Global Sinusitis Treatment Market Size, Share, and Analysis, By Disease (Acute Sinusitis, Sub-acute Sinusitis, and Chronic Sinusitis), By Age (Paediatrics, Adults), By Treatment (Surgery, Analgesics, Corticosteroids, Antihistamines, Quinolones, Antibiotics, Sulphonamides), By Route of Administration (Injectable, Nasal, Topical, Oral), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hospital Pharmacies), By End User (Hospitals, Speciality Clinics, Homecare, Others) and Regional Forecasts, 2022-2032


PRODUCT OVERVIEW

Global Sinusitis Treatment Market size was USD 3.06 billion in 2021 and projected to grow from USD 3.3 billion in 2023 to USD 4.7 billion by 2032, exhibiting a CAGR of 4% during the forecast period.

Sinusitis is caused due to the blockage of nasal cavity by accumulation of fluid due to the presence of various germs like virus and bacteria. The tissue lining sinuses are air-filled pockets which get swollen in case of sinusitis and it may be either acute or chronic and can result in advancing to complications like meningitis and brain abscess if not treated. Sinusitis can be diagnosed with various ciliary function tests, blood tests, sinus CT scans, nasal cytology & allergy testing etc., and the treatment involves decongestants to surgery based on the severity.

MARKET HIGHLIGHTS

Global Sinusitis Treatment Market is expected to reach USD 4.7 billion, growing at a CAGR of 4% during forecast period owing to the increasing sinusitis due to the pollution, growing demand for diagnostic tests and treatment, and growing advancements in technology related to sinusitis surgery which are all driving the demand for the growth of the Global Sinusitis Treatment Market. Increasing utilization of medical devices for diagnosis and treatment purpose and increasing treatment options using nasal corticosteroids, nasal sprays, decongestants etc. are boosting the growth of market.

Global Sinusitis Treatment Market Segments:
  • Disease
  • Acute Sinusitis
  • Sub-acute Sinusitis
  • Chronic Sinusitis
  • Age
  • Paediatrics
  • Adults
  • Treatment
  • Surgery
  • Analgesics
  • Corticosteroids
  • Antihistamines
  • Quinolones
  • Antibiotics
  • Sulphonamides
  • Route of Administration
  • Injectable
  • Nasal
  • Topical
  • Oral
  • Distribution Channel
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • End User
  • Hospitals
  • Speciality Clinics
  • Homecare
  • Others
MARKET DYNAMICS

Growth Drivers

Growing Treatment Options is Expected to Boost the Growth of the Market

Advancements in Technology is Expected to Boost the Growth of the Market

Restraint

Adverse Effects by Drugs May Restrain the Growth of the Market

Key Players
  • Bayer AG
  • Sanofi
  • Pfizer Inc.
  • OptiNose US, Inc.
  • GSK plc.
  • Regeneron Pharmaceuticals Inc
  • Novartis AG
  • Teva Pharmaceutical Industries
  • Sanofi
  • Mylan N.V
  • Fresenius Kabi USA
  • Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)
Global Laboratory Temperature Control Units Market is further segmented by region into:
  • North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
  • Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
  • Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
  • Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
  • Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
Reasons to Purchase this Report
  • Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 3-month post-sales analyst support.
*Please Note: The report will be delivered in 4-5 business days upon order confirmation*

Table of Contents

371 Pages
1. Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Global Sinusitis Treatment Market: COVID-19. Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2. Global Sinusitis Treatment Market: COVID-19. Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Global Sinusitis Treatment Market – Industry Insights
4.1. Industry Segmentation
4.2. COVID-19. overview on world economy
4.3. Industry ecosystem Channel analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porters Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. Global Sinusitis Treatment Market
10.1. Overview
10.2. Historical Analysis (2016-2021)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Global Sinusitis Treatment Market Size & Forecast 202. A-203. F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Disease
11.3.1.1. Acute Sinusitis
11.3.1.1.1. By Value (USD Million) 2022-203. F
11.3.1.1.2. Market Share (%) 2022-203. F
11.3.1.1.3. Y-o-Y Growth (%) 2022-203. F
11.3.1.2. Sub-acute Sinusitis
11.3.1.2.1. By Value (USD Million) 2022-203. F
11.3.1.2.2. Market Share (%) 2022-203. F
11.3.1.2.3. Y-o-Y Growth (%) 2022-203. F
11.3.1.3. Chronic Sinusitis
11.3.1.3.1. By Value (USD Million) 2022-203. F
11.3.1.3.2. Market Share (%) 2022-203. F
11.3.1.3.3. Y-o-Y Growth (%) 2022-203. F
11.3.2. By Age
11.3.2.1. Paediatrics
11.3.2.1.1. By Value (USD Million) 2022-203. F
11.3.2.1.2. Market Share (%) 2022-203. F
11.3.2.1.3. Y-o-Y Growth (%) 2022-203. F
11.3.2.2. Adults
11.3.2.2.1. By Value (USD Million) 2022-203. F
11.3.2.2.2. Market Share (%) 2022-203. F
11.3.2.2.3. Y-o-Y Growth (%) 2022-203. F
11.3.3. By Treatment
11.3.3.1. Surgery
11.3.3.1.1. By Value (USD Million) 2022-203. F
11.3.3.1.2. Market Share (%) 2022-203. F
11.3.3.1.3. Y-o-Y Growth (%) 2022-203. F
11.3.3.2. Analgesics
11.3.3.2.1. By Value (USD Million) 2022-203. F
11.3.3.2.2. Market Share (%) 2022-203. F
11.3.3.2.3. Y-o-Y Growth (%) 2022-203. F
11.3.3.3. Corticosteroids
11.3.3.3.1. By Value (USD Million) 2022-203. F
11.3.3.3.2. Market Share (%) 2022-203. F
11.3.3.3.3. Y-o-Y Growth (%) 2022-203. F
11.3.3.4. Antihistamines
11.3.3.4.1. By Value (USD Million) 2022-203. F
11.3.3.4.2. Market Share (%) 2022-203. F
11.3.3.4.3. Y-o-Y Growth (%) 2022-203. F
11.3.3.5. Quinolones
11.3.3.5.1. By Value (USD Million) 2022-203. F
11.3.3.5.2. Market Share (%) 2022-203. F
11.3.3.5.3. Y-o-Y Growth (%) 2022-203. F
11.3.3.6. Antibiotics
11.3.3.6.1. By Value (USD Million) 2022-203. F
11.3.3.6.2. Market Share (%) 2022-203. F
11.3.3.6.3. Y-o-Y Growth (%) 2022-203. F
11.3.3.7. Sulphonamides
11.3.3.7.1. By Value (USD Million) 2022-203. F
11.3.3.7.2. Market Share (%) 2022-203. F
11.3.3.7.3. Y-o-Y Growth (%) 2022-203. F
11.3.4. By Route of Administration
11.3.4.1. Injectable
11.3.4.1.1. By Value (USD Million) 2022-203. F
11.3.4.1.2. Market Share (%) 2022-203. F
11.3.4.1.3. Y-o-Y Growth (%) 2022-203. F
11.3.4.2. Nasal
11.3.4.2.1. By Value (USD Million) 2022-203. F
11.3.4.2.2. Market Share (%) 2022-203. F
11.3.4.2.3. Y-o-Y Growth (%) 2022-203. F
11.3.4.3. Topical
11.3.4.3.1. By Value (USD Million) 2022-203. F
11.3.4.3.2. Market Share (%) 2022-203. F
11.3.4.3.3. Y-o-Y Growth (%) 2022-203. F
11.3.4.4. Oral
11.3.4.4.1. By Value (USD Million) 2022-203. F
11.3.4.4.2. Market Share (%) 2022-203. F
11.3.4.4.3. Y-o-Y Growth (%) 2022-203. F
11.3.5. By Distribution Channel
11.3.5.1. Retail Pharmacies
11.3.5.1.1. By Value (USD Million) 2022-203. F
11.3.5.1.2. Market Share (%) 2022-203. F
11.3.5.1.3. Y-o-Y Growth (%) 2022-203. F
11.3.5.2. Online Pharmacies
11.3.5.2.1. By Value (USD Million) 2022-203. F
11.3.5.2.2. Market Share (%) 2022-203. F
11.3.5.2.3. Y-o-Y Growth (%) 2022-203. F
11.3.5.3. Hospital Pharmacies
11.3.5.3.1. By Value (USD Million) 2022-203. F
11.3.5.3.2. Market Share (%) 2022-203. F
11.3.5.3.3. Y-o-Y Growth (%) 2022-203. F
11.3.6. By End User
11.3.6.1. Hospitals
11.3.6.1.1. By Value (USD Million) 2022-203. F
11.3.6.1.2. Market Share (%) 2022-203. F
11.3.6.1.3. Y-o-Y Growth (%) 2022-203. F
11.3.6.2. Speciality Clinics
11.3.6.2.1. By Value (USD Million) 2022-203. F
11.3.6.2.2. Market Share (%) 2022-203. F
11.3.6.2.3. Y-o-Y Growth (%) 2022-203. F
11.3.6.3. Homecare
11.3.6.3.1. By Value (USD Million) 2022-203. F
11.3.6.3.2. Market Share (%) 2022-203. F
11.3.6.3.3. Y-o-Y Growth (%) 2022-203. F
11.3.6.4. Others
11.3.6.4.1. By Value (USD Million) 2022-203. F
11.3.6.4.2. Market Share (%) 2022-203. F
11.3.6.4.3. Y-o-Y Growth (%) 2022-203. F
12. North America Sinusitis Treatment Market Size & Forecast 202. A-203. F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Disease
12.3.2. By Age
12.3.3. By Treatment
12.3.4. By Route of Administration
12.3.5. By Distribution Channel
12.3.6. By End User
12.4. Country
12.4.1. United States
12.4.2. Canada
13. Europe Sinusitis Treatment Market Size & Forecast 202. A-203. F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Disease
13.3.2. By Age
13.3.3. By Treatment
13.3.4. By Route of Administration
13.3.5. By Distribution Channel
13.3.6. By End User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Sinusitis Treatment Market Size & Forecast 202. A-203. F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Disease
14.3.2. By Age
14.3.3. By Treatment
14.3.4. By Route of Administration
14.3.5. By Distribution Channel
14.3.6. By End User
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Sinusitis Treatment Market Size & Forecast 202. A-203. F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Disease
15.3.2. By Age
15.3.3. By Treatment
15.3.4. By Route of Administration
15.3.5. By Distribution Channel
15.3.6. By End User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Sinusitis Treatment Market Size & Forecast 202. A-203. F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Disease
16.3.2. By Age
16.3.3. By Treatment
16.3.4. By Route of Administration
16.3.5. By Distribution Channel
16.3.6. By End User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2021
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. Bayer AG
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3. Yrs.)
18.1.4.5. Executive Team
18.2. Sanofi
18.3. Pfizer Inc.
18.4. OptiNose US, Inc.
18.5. GSK plc.
18.6. Regeneron Pharmaceuticals Inc
18.7. Novartis AG
18.8. Teva Pharmaceutical Industries
18.9. Sanofi
18.10. Mylan N.V
18.11. Fresenius Kabi USA
18.12. Other Prominent Players
19. Appendix
20. Consultant Recommendation

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us